Whitney & Co’s Core Laboratories CLB Stock Holding History

Whitney & Co’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,730	Closed	-$111K	–	105
2020 Q1	$111K	Sell	10,730 -5,542	-34%	-$155K	0.03%	97
2019 Q4	$613K	Buy	16,272 +10,697	+192%	+$481K	0.12%	80
2019 Q3	$272K	Buy	+5,575	New	+$259K	0.06%	97

Other funds holding CLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Whitney & Co's CLB Position: Q2 2020 in Review

Whitney & Co sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 10,730 shares — an estimated $111K sold.

Whitney & Co first reported a position in CLB in Q3 2019 and held it in 3 quarters. The position peaked at $613K in Q4 2019. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

Whitney & Co reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
Whitney & Co sold 10,730 Core Laboratories shares in Q2 2020, an estimated $111K.
Whitney & Co first reported a position in Core Laboratories in Q3 2019 and held it in 3 quarters.
Whitney & Co's Core Laboratories position peaked at $613K in Q4 2019.
197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on Whitney & Co's 13F filing for Q2 2020, filed 13 Aug 2020.